GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iAnthus Capital Holdings Inc (XCNQ:IAN) » Definitions » EBITDA Margin %

iAnthus Capital Holdings (XCNQ:IAN) EBITDA Margin % : 11.39% (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is iAnthus Capital Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. iAnthus Capital Holdings's EBITDA for the three months ended in Dec. 2024 was C$6.9 Mil. iAnthus Capital Holdings's Revenue for the three months ended in Dec. 2024 was C$60.9 Mil. Therefore, iAnthus Capital Holdings's EBITDA margin for the quarter that ended in Dec. 2024 was 11.39%.


iAnthus Capital Holdings EBITDA Margin % Historical Data

The historical data trend for iAnthus Capital Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iAnthus Capital Holdings EBITDA Margin % Chart

iAnthus Capital Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -151.09 3.92 -233.25 -1.63 12.66

iAnthus Capital Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 4.70 20.34 14.04 11.39

Competitive Comparison of iAnthus Capital Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, iAnthus Capital Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iAnthus Capital Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iAnthus Capital Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where iAnthus Capital Holdings's EBITDA Margin % falls into.


;
;

iAnthus Capital Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

iAnthus Capital Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=30.231/238.733
=12.66 %

iAnthus Capital Holdings's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=6.931/60.86
=11.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iAnthus Capital Holdings  (XCNQ:IAN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


iAnthus Capital Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of iAnthus Capital Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


iAnthus Capital Holdings Business Description

Traded in Other Exchanges
Address
214 King Street, Suite 314, Toronto, ON, CAN, M5H 3S6
iAnthus Capital Holdings Inc owns and operates licensed cannabis cultivators, processors, and dispensaries throughout the United States. The company's operating segments include the Eastern Region and Western Region. It generates a majority of its revenue from the Eastern Region. The Eastern Region includes the company's operations in Florida, Maryland, Massachusetts, New York, New Jersey, Vermont, and its CBD business. Its Western Region includes the company's operations in Arizona, Colorado, and Nevada.
Executives
Alexander Azim Shoghi Director
Elizabeth M. Stavola Director, Senior Officer
Jr. Robert Michael Whelan Director
Hadley Ford Director, Senior Officer
Randy Maslow Director, Senior Officer
Patrick Tiernan Senior Officer
Julius John Kalcevich Senior Officer

iAnthus Capital Holdings Headlines

No Headlines